Publications

Publications

Scientific contributions highlighting the impact of Diatech Pharmacogenetics technologies in diagnostics.

Filter

All years 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2008
All product lines Easy Easy PGX Helix Microsatelliti Myriapod Myriapod NGS Realquant Response
  • Myriapod

Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer

  • Myriapod

Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest. European Journal of Cancer

  • Myriapod

Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma. Oncology Letters

  • Myriapod

Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept. Neuro-Oncology

  • Myriapod

Management optimization of non small cell lung cancer (NSCLC) specimens. A single institution experience with a multiplexed mass spectrometry approach. Annals of Oncology

  • Myriapod, Response

The impact of mass spectrometry multigenic platform on the management of metastatic colorectal patients. Annals of Oncology

  • Myriapod

Frequency of driver mutations in EGFR wt NSCLC using mass spectrometry: Experience of Area Vasta Romagna. Annals of Oncology

  • Myriapod

Detection of early genetic and epigenetic alterations in NSCLC by using mass spectrometry and pyrosequencing analysis. Annals of Oncology

  • Myriapod, Response

Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors. Future Oncology

  • Myriapod

Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example. Onco Targets and Therapy

Your next step starts here. Fill out the form and talk to us

Let's talk